• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:赵晓曄,卜轶卓,游翠玉,张雨晨,何江川,郑云鹤,王珂.黄芩素-锌配合物纳米给药系统的制备及其用于小鼠炎症性肠病的作用研究[J].中国现代应用药学,2024,41(19):1-6.
zhaoxiaoye,buyizhuo,youcuiyu,zhangyuchen,hejiangchuan,zhengyunhe,wangke.Preparation of the Baicalein-Zinc Complex Nano-Delivery System and Effect on Inflammatory Bowel Disease in Mice[J].Chin J Mod Appl Pharm(中国现代应用药学),2024,41(19):1-6.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 8次   下载 4 本文二维码信息
码上扫一扫!
分享到: 微信 更多
黄芩素-锌配合物纳米给药系统的制备及其用于小鼠炎症性肠病的作用研究
赵晓曄,卜轶卓,游翠玉,张雨晨,何江川,郑云鹤,王珂
1.西安交通大学第一附属医院;2.西安交通大学
摘要:
目的 制备黄芩素-锌(Ba-Zn)配合物纳米给药系统,用于治疗小鼠的炎症性肠病(IBD)。方法 制备黄芩素-锌金属配合物,用硫酸软骨素(CS)修饰后自组装形成Ba-Zn@CS纳米给药系统,采用FT-IR、TEM进行表征,测定其粒径、电位;建立小鼠IBD模型,通过小鼠疾病活动指数(DAI)、结肠长度变化、结肠组织病理学分析等方法评价Ba-Zn@CS纳米给药系统在IBD小鼠体内的药效。结果 FT-IR及TEM证明了Ba-Zn@CS的成功合成,其粒径为356.4 nm,PDI为0.129,表面zeta电位为-35.7 mV。体内药效评价显示,Ba-Zn@CS组的小鼠体重下降情况明显缓解,DAI评分降低,结肠长度大于模型组小鼠(p<0.05),结肠组织病理检查显示Ba-Zn@CS组的小鼠结肠局部炎症明显缓解。结论 Ba-Zn@CS给药系统改善了Ba游离药物的体内抗炎症性肠病作用,缓解了IBD小鼠的局部炎症,为提高Ba的生物利用度以治疗IBD提供了新思路。
关键词:  黄芩素  配合物    硫酸软骨素  炎症性肠病
DOI:
分类号:
基金项目:国家自然科学(82204294,32171336);中国医学科学院中央级公益性科研院所基本科研业务费专项资金(2022-JKCS-003)
Preparation of the Baicalein-Zinc Complex Nano-Delivery System and Effect on Inflammatory Bowel Disease in Mice
zhaoxiaoye1,2,3, buyizhuo1,2,3, youcuiyu4,2,3, zhangyuchen4,2,3, hejiangchuan4,2,3, zhengyunhe4,2,3, wangke4,2,3
1.The First Affiliated Hospital of Xi'2.'3.an Jiaotong University;4.Xi'
Abstract:
OBJECTIVE To prepare Baicalein-Zinc(Ba-Zn)complex nano-delivery system for the treatment of inflammatory bowel disease (IBD) in mice. METHODS The Ba-Zn complex was synthesized, and it was modified with chondroitin sulfate(CS)to prepare Ba-Zn@CS nanoparticles self-assembly. Ba-Zn@CS nanoparticles were characterized by FT-IR and TEM, and its particle size, potential were determined. The therapeutic effect of the Ba-Zn@CS was evaluated in the IBD mice from aspects such as the disease activity index(DAI), the length of the colon length, and the pathological analysis of colon tissue pathology. RESULTS FT-IR and TEM proved that the successful construction of Ba-Zn@CS nanoparticles with a particle size of 356.4 nm, PDI of 0.129, surface zeta potential of -35.7 mV. The in vivo efficacy evaluation showed that the weight loss of the Ba-Zn@CS treatment group was significantly alleviated, the DAI was reduced, and the colon length was longer than the mice of the model group (P < 0.05). The pathological examination of colon tissue showed that the mice in the Ba-Zn@CS treatment group have a significant alleviating local inflammation of the colon. CONCLUSION Ba-Zn@CS NPs exerted significant anti-IBD effects. It provided a new idea for improving Ba's biological utilization to the treatment of IBD.
Key words:  baicalein  complex  zinc  chondroitin sulfate  inflammatory bowel disease
扫一扫关注本刊微信